Oral oestrogens for preventing recurrent urinary tract infection in postmenopausal women
Sübutlu məlumatların xülasələri
29.11.2012 • Sonuncu dəyişiklik 29.11.2012
Editors
Oral oestrogens appear not to be effective for reducing recurrent urinary tract infections compared to placebo in postmenopausal women.
A Cochrane review included 4 studies with a total of 2798 women. Oral oestrogens did not reduce UTI compared to placebo (RR 1.08, 95% CI 0.88 to 1.33, 4 trials, n=2798). Adverse events were breast tenderness, vaginal bleeding or spotting.
Comment: The quality of evidence is downgraded by study quality (unclear allocation concealment).
The following decision support rules contain links to this evidence summary:
- Local rather than oral estrogens for recurrent urinary tract infection in postmenopausal women
Ədəbiyyat
- Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008 Apr 16;(2):CD005131.